SPEROGENIX

Welcome to the Brand page for “SPEROGENIX”, which is offered here for Medicines for human purposes, medicines for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; pharmaceutical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; chemico-pharmaceutical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; chemical preparations for pharmaceutical purposes for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; chemical preparations for medical purposes, chemical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; biochemical drugs in the nature of pharmaceutical preparations for the treatment of pulmonary vascular diseases, neurological diseases, inherited metabolic diseases, non-onco hematologic diseases; diagnostic preparations for medical purposes; dietetic foods adapted for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “SPEROGENIX” is believed to be currently owned by “Beijing Rareplus MedTech Co., Ltd.”